Weighted Average Number of Shares Outstanding, Basic of LUMOS PHARMA, INC. from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
LUMOS PHARMA, INC. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q3 2010 to Q3 2024.
  • LUMOS PHARMA, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2024 was 8.33M shares, a 4.38% increase year-over-year.
  • LUMOS PHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 8.15M shares, a 2.73% decline from 2022.
  • LUMOS PHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 8.37M shares, a 0.47% increase from 2021.
  • LUMOS PHARMA, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 8.33M shares, a 23% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

LUMOS PHARMA, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 8.33M +349K +4.38% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 8.11M -52K -0.64% 01 Apr 2024 30 Jun 2024 10-Q 02 Aug 2024
Q1 2024 8.1M -135K -1.64% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q4 2023 8.15M -229K -2.73% 01 Oct 2023 31 Dec 2023 10-K 07 Mar 2024
Q3 2023 7.98M -410K -4.88% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 8.16M -202K -2.41% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024
Q1 2023 8.24M -118K -1.41% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 8.37M +39.3K +0.47% 01 Oct 2022 31 Dec 2022 10-K 07 Mar 2024
Q3 2022 8.39M +30.6K +0.37% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 8.37M -366K -4.19% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 8.36M +41.1K +0.49% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023
Q4 2021 8.33M 01 Oct 2021 31 Dec 2021 10-K 07 Mar 2023
Q3 2021 8.36M +64.1K +0.77% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 8.73M +439K +5.3% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022
Q1 2021 8.32M 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q3 2020 8.29M +6.95M +517% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021
Q2 2020 8.29M 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q3 2019 1.34M 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q1 2017 29.2M +357K +1.24% 01 Jan 2017 31 Mar 2017 10-Q 05 May 2017
Q4 2016 29M +393K +1.37% 01 Oct 2016 31 Dec 2016 10-K 06 Mar 2017
Q3 2016 29M +249K +0.87% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2016
Q2 2016 28.9M +230K +0.8% 01 Apr 2016 30 Jun 2016 10-Q 05 Aug 2016
Q1 2016 28.9M +638K +2.26% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017
Q4 2015 28.6M 01 Oct 2015 31 Dec 2015 10-K 06 Mar 2017
Q3 2015 28.7M 01 Jul 2015 30 Sep 2015 10-Q 08 Nov 2016
Q2 2015 28.7M 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016
Q1 2015 28.2M +613K +2.22% 01 Jan 2015 31 Mar 2015 10-Q 29 Apr 2016
Q1 2014 27.6M 01 Jan 2014 31 Mar 2014 10-Q/A 24 Aug 2015
Q4 2012 20.8M +14.7M +243% 01 Oct 2012 31 Dec 2012 10-K 16 Mar 2015
Q3 2012 20.9M +17.2M +471% 01 Jul 2012 30 Sep 2012 10-Q 31 Oct 2012
Q2 2012 20.7M +17M +467% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2012
Q1 2012 20.6M +17M +467% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2012
Q4 2011 6.06M 01 Oct 2011 31 Dec 2011 10-K 30 Mar 2012
Q3 2011 3.66M +286K +8.49% 01 Jul 2011 30 Sep 2011 10-Q 31 Oct 2012
Q2 2011 3.65M 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012
Q1 2011 3.64M 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012
Q3 2010 3.37M 01 Jul 2010 30 Sep 2010 10-Q/A 17 Jan 2012

LUMOS PHARMA, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 8.15M -229K -2.73% 01 Jan 2023 31 Dec 2023 10-K 07 Mar 2024
2022 8.37M +39.3K +0.47% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024
2021 8.33M +1.56M +23% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2023
2020 6.78M 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2022
2016 29M +393K +1.37% 01 Jan 2016 31 Dec 2016 10-K 06 Mar 2017
2015 28.6M +748K +2.69% 01 Jan 2015 31 Dec 2015 10-K 06 Mar 2017
2014 27.8M +2.56M +10.1% 01 Jan 2014 31 Dec 2014 10-K 06 Mar 2017
2013 25.3M +4.5M +21.6% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016
2012 20.8M +14.7M +243% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015
2011 6.06M +2.71M +80.9% 01 Jan 2011 31 Dec 2011 10-K 30 Mar 2012
2010 3.35M 01 Jan 2010 31 Dec 2010 10-K 30 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.